{"text": "Reagents and Chemicals", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Necrostatin analogs were synthesized as previously described [ 23 ] , [ 24 ] .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The following reagents and final concentrations ( unless otherwise specified in the text / figures ) were used in the experiments : Akt inhibitor VIII ( 10 microM , Calbiochem ) , MK-2206 ( 10 microM , Selleck Chem ) , Triciribine ( 100 microM , National Cancer Institute ) , SP600125 ( 10 microM , Calbiochem ) , JNK inhibitor VIII ( 10 microM , Calbiochem ) , UO126 ( 10 mM , Cayman Chem ) , PD169316 ( 10 microM , Calbiochem ) , LiCl ( 10 mM , Sigma ) , SB216763 ( 10 microM , Calbiochem ) , BX912 ( 10 microM , Axon Med Chem ) , PF-4706871 ( Sigma ) , rapamycin ( 100 nM , Santa Cruz ) , PI-103 ( 10 microM , Calbiochem ) , Torin-1 ( 500 nM , gift of Dr . Nathanael Grey ( Harvard Medical School ) , LY249002 ( 10 microM , Cell Signaling ) , PD173074 ( 2 microM , Cayman Chem ) , PD166866 ( 20 microM , Calbiochem ) , 4EGI-1 ( 50 microM , Calbiochem ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Pan-caspase inhibitor zVAD.fmk ( 20-30 microM ) was purchased from Bachem .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Human and mouse <extra_id_0> TNFalpha <extra_id_2> Protein <extra_id_1> ( 10 ng / ml ) , human <extra_id_0> bFGF <extra_id_2> Protein <extra_id_1> ( 25 ng / ml ) , <extra_id_0> EGF <extra_id_2> Protein <extra_id_1> ( 50 ng / ml ) , PDGF-BB ( 20 ng / ml ) , and <extra_id_0> IGF-1 <extra_id_2> Protein <extra_id_1> ( 50 ng / ml ) were from Cell Sciences or Peprotech .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "All other reagents were from Sigma .", "event": "<extra_id_0> <extra_id_1>"}
